Scribd Logo
Upload

Welcome to Scribd!

  • 1 views

    Annual Report 27

    Uploaded by

    metspray.blr
    report

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Annual Report 27

    Uploaded by

    metspray.blr
    1 views1 page
    report

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    report

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    1 views1 page

    Annual Report 27

    Uploaded by

    metspray.blr
    report

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Biotechnology Industry Research Assistance Council (BIRAC)

    Management Discussion & Analysis Report


    (Forming Part of the Directors Report for 2012-13)

    INDUSTRIAL STRUCTURE AND DEVELOPMENT affordable.


    BIRAC has been set up as a Public Sector Section 25 • Bring a transformational change to the biotechnology
    Not for profit Company on 20th March 2012. It is a unique sector of the country by fostering and nurturing the next
    organization, the first of its kind in the country and has generation of ‘enterprise builders’ who would help deliver
    been set up to match global standards. The Company is innovative biotechnology products and services that can
    committed to deliver the required outcome of promoting, solve the unmet needs of the country be it in healthcare,
    nurturing and enabling the Biotech Innovation Eco-system agriculture, bio-energy and industrial biotechnology.
    for affordable product development. Today there is an
    • Reduce the risk inherent in the innovation pipeline
    urgent need to create, support and sustain an Innovation
    from the origination of an ‘idea’ and its journey through
    Ecosystem and an Institutional framework in the country,
    several hurdles such as at prototype, at pilot and at scale
    which not only provides investment for discovery to early
    up stages, to become a successful commercialized
    stage to product development and commercialization,
    product.
    but also address critical gaps in skilled Human Resource,
    • Provide a 360° mechanism for biotech firms to take their
    infrastructure and relevant research resource. BIRAC
    idea to final commercial product.
    addressed these needs and aim at enhancing the risk
    taking ability of the biotech enterprise and catalysing the • Provide support to other foundational structures of a
    growth of innovation research to achieve the target of US biotech innovation ecosystem namely bio-incubators,
    $100 billion by 2025. technology transfers and high end technology platforms
    that provide access to high end technology tools.

    STRENGTH AND OPPORTUNITIES • Create new models of engagement among industry,

    Since BIRAC is a unique organisation first-its-kind, set up academia and the third sector and build porous

    in the country to nurture and support growth of the biotech boundaries for critical and important information to flow
    among all stakeholders. For this to be realised, BIRAC
    sector; it requires a very special and unique governance
    envisages itself to be at the intersection of each of the
    structure for successful and effective functioning.
    dynamic ecosystems viz. industry, academia and the
    BIRAC’s core mission is to work as a Development Agency third sector.
    in the field of biotechnology and address the national needs • Kindle the spirit of bio-entrepreneurship in academia
    of health and food security problems through bottom up and enable spin outs from academic and public funded
    competitive grant approach or through top down product research centres.
    development programmes. To achieve this aim, BIRAC is
    • Build national and international partnerships with similarly
    working in partnership with private, public and international aligned organisations in delivering its mandate.
    groups and the aim is to:

    • Play a catalytic role in fashioning, building and scaling RISK AND GOVERNANCE
    a true Indian bio-economy that puts biotechnology at The steady growth of the Biotech Sector at about 20%
    the centre stage of the growth story of India, addresses is indicative of the potential, which will help the sector
    the multitudes of challenges that the country faces and to achieve a target of US $100 billion by 2025. However
    helps in delivering solutions that are innovative and sustained growth to its full potential requires creation of the

    Annual Report 2012-13 22

    You might also like